市場調查報告書
商品編碼
1297129
數位化糖尿病管理市場規模 - 按產品類型(設備、服務),按患者類型(1型、2型),按終端用戶(醫院、家庭設置、診斷中心和診所) - 全球預測至2032年Digital Diabetes Management Market Size - By Product Type (Devices, Services), By Patient Type (Type 1, Type 2), By End-Use (Hospitals, Home Settings, Diagnostic Centers & Clinics) - Global Forecast to 2032 |
全球數位糖尿病管理市場規模將在2032年之前呈指數級成長。對糖尿病的醫療保健支出不斷增加是積極影響行業成長的關鍵因素。全球糖尿病負擔的增加,迫使世界各地的許多政府對數位糖尿病管理解決方案進行大量投資,用於遠程監測病人。事實上,許多政府也對先進的糖尿病管理設備實施了有利的報銷政策,這將進一步塑造行業格局。該領域的商業巨頭正強調開發先進的診斷設備,以加強他們的地位,為市場打開新的成長途徑。
整個數位糖尿病管理市場根據產品、病人、終端用途和地區進行分類。
在產品方面,數位糖尿病管理設備的市場價值將在2032年之前描繪出可觀的收益。糖尿病發生率的上升,加上人們對糖尿病護理的個性化傾向的激增,增加了對數位糖尿病管理設備的需求。此外,這些設備提供了便利和易用性,使個人更簡單地監測他們的血糖水平和管理他們的糖尿病日常。
基於病人,1型的行業規模從2023年到2032年將以超過19%的年復合成長率成長。 1型糖尿病患病率的激增,增加了數位糖尿病管理解決方案的採用。事實上,用於血糖監測、營養控制、胰島素滴定和胰島素輸送的行動應用程式在1型糖尿病患者中越來越受歡迎,用於健康追踪。此外,這一人群高度依賴胰島素,這增加了胰島素遞送設備的採用。
基於終端用途,診斷中心和診所部分的行業價值將在2032年之前見證重大收益。先進的胰島素輸送設備的高可用性增加了病人對診斷中心和診所的訪問。許多診斷中心現在提供與數位平台和電子健康記錄系統的無縫整合。這種整合允許個人以數位方式接收他們的測試結果,查看一段時間的趨勢,並輕鬆地與他們的醫療保健提供者或數位糖尿病管理應用程式分享數據。
從區域來看,歐洲數位糖尿病管理市場規模到2032年將達到320億美元。德國、法國、義大利和西班牙等國家的糖尿病發病率不斷成長,增加了該地區對數位糖尿病管理解決方案的採用。此外,區域擴張也可歸因於領先的行業巨頭,如霍夫曼-羅氏有限公司和其他公司強調產品創新以保持其行業地位。
Global Digital Diabetes Management Market size will expand exponentially through 2032. Growing healthcare expenditure towards diabetes is the key factor positively impacting the industry growth. Increasing global burden of diabetes has compelled many governments across the world to invest considerable amounts into digital diabetes management solutions for remote patient monitoring. In fact, many governments have also implemented favorable reimbursement policies for advanced diabetes management devices, which will further shape the industry landscape. Business behemoths in the space are emphasizing developing advanced diagnostic devices to strengthen their position, opening new growth avenues for the market.
The overall digital diabetes management market is categorized based on product, patient, end-use, and region.
In terms of product, digital diabetes management devices market value will depict considerable gains through 2032. Rising occurrence of diabetes, coupled with the surging inclination of people towards a personalized approach to diabetes care, has increased the demand for digital diabetes management devices. Additionally, these devices offer convenience and ease of use, making it simpler for individuals to monitor their blood glucose levels and manage their diabetes daily.
Based on patient, industry size from the type 1 segment will grow at over 19% CAGR from 2023 to 2032. Surging prevalence of type 1 diabetes has increased the adoption of digital diabetes management solutions. In fact, mobile apps for glucose monitoring, nutrition control, insulin titration, and insulin delivery have become increasingly popular among type 1 diabetic people for health tracking. Moreover, this demographic is highly dependent on insulin, which has increased the adoption of insulin-delivery devices.
Based on end-use, industry value from the diagnostic centers & clinics segment will witness significant gains through 2032. High availability of advanced insulin delivery devices has increased patient visits to diagnostic centers & clinics. Many diagnostic centers now offer seamless integration with digital platforms and electronic health record systems. This integration allows individuals to receive their test results digitally, view trends over time, and easily share data with their healthcare providers or digital diabetes management applications.
Regionally, Europe digital diabetes management market size will reach USD 32 billion by 2032. Growing incidence of diabetes in countries such as Germany, France, Italy, and Spain has increased the adoption of digital diabetes management solutions in the region. Moreover, regional expansion can also be attributed to the presence of leading industry giants such as F. Hoffmann-La Roche Ltd and others emphasizing product innovations to retain their industry standing.